115 related articles for article (PubMed ID: 8057532)
41. Parametric studies on phencyclidine enhancement of 3H quinuclidinyl benzilate accumulation in vivo.
Boggan WO; Faught K; Boyd S; Middaugh LD
Pharmacol Biochem Behav; 1988 May; 30(1):31-5. PubMed ID: 3174753
[TBL] [Abstract][Full Text] [Related]
42. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
[TBL] [Abstract][Full Text] [Related]
43. Muscarinic acetylcholine receptor subtype mRNA expression and ligand binding in the aged rat forebrain.
Blake MJ; Appel NM; Joseph JA; Stagg CA; Anson M; de Souza EB; Roth GS
Neurobiol Aging; 1991; 12(3):193-9. PubMed ID: 1876225
[TBL] [Abstract][Full Text] [Related]
44. Long-term changes in gerbil brain neurotransmitter receptors following transient cerebral ischaemia.
Araki T; Kato H; Kogure K; Kanai Y
Br J Pharmacol; 1992 Oct; 107(2):437-42. PubMed ID: 1330176
[TBL] [Abstract][Full Text] [Related]
45. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
46. Autoradiographic analysis of second-messenger and neurotransmitter receptor systems in the exo-focal remote areas of postischemic rat brain.
Nagasawa H; Araki T; Kogure K
Brain Res Bull; 1994; 35(4):347-52. PubMed ID: 7850485
[TBL] [Abstract][Full Text] [Related]
47. Region-specific changes in CNS muscarinic acetylcholine receptors in a rat model of hyperammonemia.
Rukmini Devi RP; Murthy CR
Biochem Pharmacol; 1998 Jul; 56(2):237-41. PubMed ID: 9698078
[TBL] [Abstract][Full Text] [Related]
48. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
[TBL] [Abstract][Full Text] [Related]
49. Binding of [3H]quinuclidinyl benzilate to intestinal mucus. An artifact in identification of epithelial cell muscarinic receptors.
Rimele TJ; Gaginella TS
Biochem Pharmacol; 1982 Feb; 31(4):515-20. PubMed ID: 7066020
[TBL] [Abstract][Full Text] [Related]
50. Reduced muscarinic receptor binding in tissues of rats tolerant to the insecticide disulfoton.
Schwab BW; Hand H; Costa LG; Murphy SD
Neurotoxicology; 1981 Dec; 2(4):635-47. PubMed ID: 7200580
[TBL] [Abstract][Full Text] [Related]
51. Long-term potentiation is associated with increased [3H]AMPA binding in rat hippocampus.
Tocco G; Maren S; Shors TJ; Baudry M; Thompson RF
Brain Res; 1992 Feb; 573(2):228-34. PubMed ID: 1380390
[TBL] [Abstract][Full Text] [Related]
52. High correlation between the localization of [3H]TCP binding and NMDA receptors.
Maragos WF; Chu DC; Greenamyre JT; Penney JB; Young AB
Eur J Pharmacol; 1986 Apr; 123(1):173-4. PubMed ID: 3011454
[No Abstract] [Full Text] [Related]
53. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
54. Bidirectional transport of NMDA receptor and ionophore in the vagus nerve.
Cincotta M; Beart PM; Summers RJ; Lodge D
Eur J Pharmacol; 1989 Jan; 160(1):167-71. PubMed ID: 2540989
[TBL] [Abstract][Full Text] [Related]
55. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
[TBL] [Abstract][Full Text] [Related]
56. Muscarinic cholinergic receptors in the hippocampus of the aged rat: effects of long-term hydergine administration.
Amenta F; Cavallotti C; Franch F; Ricci A
Arch Int Pharmacodyn Ther; 1989; 297():225-34. PubMed ID: 2730238
[TBL] [Abstract][Full Text] [Related]
57. [3H]thienyl-phencyclidine ([3H]TCP) binds to two different sites in rat brain. Localization by autoradiographic and biochemical techniques.
Vignon J; Privat A; Chaudieu I; Thierry A; Kamenka JM; Chicheportiche R
Brain Res; 1986 Jul; 378(1):133-41. PubMed ID: 3742196
[TBL] [Abstract][Full Text] [Related]
58. [Effects of kamikihi-to, a Chinese traditional medicine, on various cholinergic biochemical markers in the brains of aged rats].
Egashira T; Sudo S; Murayama F; Kono T; Kudo Y; Goto S; Takayama F; Yamanaka Y
Nihon Yakurigaku Zasshi; 1991 Oct; 98(4):273-81. PubMed ID: 1802814
[TBL] [Abstract][Full Text] [Related]
59. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
60. Identification and characterization of a high-affinity glutamate-controlled TCP binding site in rat brain postsynaptic densities.
Foucaud B; Gombos G
Eur J Pharmacol; 1990 Dec; 189(6):355-62. PubMed ID: 1981559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
